Researchers hope DeepGEM can expedite targeted treatment for lung cancer patients who can't access standard genomic testing.
The Florida-based provider will work with AI software company AiraMed to analyze and measure patients' brain volume from MRIs.
NEW YORK – 858 Therapeutics on Thursday said it raised $50 million in a Series B financing round to advance its pipeline of small molecule therapeutics, including the poly (ADP) ribose glycohydrolase ...